MARKET

AGRX

AGRX

Agile
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.050
+0.040
+1.99%
After Hours: 2.050 0 0.00% 19:56 03/27 EDT
OPEN
1.950
PREV CLOSE
2.010
HIGH
2.050
LOW
1.860
VOLUME
1.49M
TURNOVER
--
52 WEEK HIGH
4.765
52 WEEK LOW
0.3500
MARKET CAP
178.47M
P/E (TTM)
-5.3497
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AGRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AGRX stock price target is 7.80 with a high estimate of 9.00 and a low estimate of 6.00.

EPS

AGRX News

More
  • Week 14 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
  • Seeking Alpha - Article · 1d ago
  • Agile Therapeutics (AGRX) Stock Remains a Top Pick, Says Analyst
  • TipRanks · 6d ago
  • Implied Volatility Surging for Agile Therapeutics (AGRX) Stock Options
  • Zacks · 03/18 13:49
  • Weekly CFO Buys Highlight
  • GuruFocus.com · 03/15 21:02

Industry

Pharmaceuticals
-0.40%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About AGRX

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of prescription contraceptive products. The Company has developed a transdermal patch technology, called Skinfusion. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.
More

Webull offers kinds of Agile Therapeutics Inc stock information, including NASDAQ:AGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGRX stock news, and many more online research tools to help you make informed decisions.